Skip to content
The Federal Trade Commission (FTC) challenge of more than 100 patent listings registered with the Food and Drug Administration, mostly for devices used to […]
The Biotechnology Innovation Organization (BIO) and patient advocacy organizations have seen some recent progress in their efforts to have Congress pass pharmacy benefit manager
House and Senate advance PBM legislation, advocacy groups urge passage Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
Blood clots are commonly missed. According to the National Blood Clot Alliance (NBCA), “fewer than 1 in 4 people have any recognition of blood
A new class of medicines provides hope for patients at risk of dangerous blood clots Read More »
Federal Trade Commission (FTC) proposals for new rules to permit more aggressive opposition to mergers would interfere with the economic ecosystem that is essential
FTC plans for aggressive merger enforcement threaten biotech innovation, BIO says Read More »
One Saturday in 2019, Mike Lavorel went out with some friends and ordered some oysters. By Monday, he was ill and by Tuesday, he
‘Miracle Man’ beat sepsis, but now needs a kidney Read More »
The law on every company’s and investor’s mind: the Inflation Reduction Act (IRA), which allows the government to set the prices of certain drugs.
How is the Inflation Reduction Act affecting biotech investment? Read More »
Women’s health has long been an underserved area when it comes to clinical innovation, R&D, and funding—the Women’s Health Innovation Opportunity Map (WHOM) is
Women’s Health Innovation Opportunity Map launches Read More »
The Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs are a great way for companies to kick-start their business. However, navigating the
What you need to know about applying for SBIR/STTR grants Read More »
Since 1999, Joe Panetta has been President & CEO and a board member of Biocom California, the state’s advocate for the life sciences industry.
How a 2017 IRS tax law could bankrupt small American biotech companies in 2023 Read More »
